Mwgzdsx Wart Remover Patches Patch
NDC Package 87957-027-01
Package Information
Mwgzdsx Wart Remover Patches (salicylic acid 40% wart remover patches) patches is wash affected area: may soak wart in warm water for 5 minutes Dry area thoroughly, remove bandage strips by peeling backing off If necessary, cut medicated patch to fit wart Carefully apply medicated plaster, repeat procedure every 48 hours as needed (until wart is removed) for up to 12 weeks. This formulation utilizes a patch delivery system. Marketed by Hubei Minxin Pharmaceutical Co., Ltd., this product is identified by NDC 87957-027 and is authorized under FDA application M028.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 87957 - Hubei Minxin Pharmaceutical Co., Ltd.
- 87957-027 - Mwgzdsx Wart Remover Patches
- 87957-027-01 - 216 PATCH in 1 BOX
- 87957-027 - Mwgzdsx Wart Remover Patches
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 87957-027-01 identifies a specific commercial package of 216 patch in 1 box of Mwgzdsx Wart Remover Patches, a human over the counter drug labeled by Hubei Minxin Pharmaceutical Co., Ltd.. This patch is formulated for topical use and contains salicylic acid as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Hubei Minxin Pharmaceutical Co., Ltd. on October 16, 2026. The current certification is valid through December 31, 2027.
How is this Hubei Minxin Pharmaceutical Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 87957002701. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.